76 related articles for article (PubMed ID: 11374801)
21. MUC1 and cathepsin D expression in early colorectal carcinoma showing V type pit pattern.
Nagata S; Tanaka S; Haruma K; Kitadai Y; Yoshihara M; Shimamoto F; Kohno N; Chayama K
Int J Oncol; 2001 Oct; 19(4):665-72. PubMed ID: 11562739
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of matrix metalloproteinase-2, cathepsin D, and tenascin-C expression in colorectal carcinoma.
Sis B; Sağol O; Küpelioğlu A; Sokmen S; Terzi C; Fuzun M; Ozer E; Bishop P
Pathol Res Pract; 2004; 200(5):379-87. PubMed ID: 15239346
[TBL] [Abstract][Full Text] [Related]
23. Comparative quantitative immunohistochemical and immunoradiometric determinations of cathepsin D in endometrial adenocarcinoma: predictors of tumor aggressiveness.
Nazeer T; Church K; Amato C; Ambros RA; Rosano TG; Malfetano JH; Ross JS
Mod Pathol; 1994 May; 7(4):469-74. PubMed ID: 8066075
[TBL] [Abstract][Full Text] [Related]
24. Cathepsin D in invasive ductal NOS, medullary, lobular and mucinous breast carcinoma. An immunohistochemical study.
Bedner E; Harezga B; Osborn M; Domagała W
Pol J Pathol; 1995; 46(1):11-5. PubMed ID: 7780691
[TBL] [Abstract][Full Text] [Related]
25. Cathepsin D as a potential prognostic marker for lung adenocarcinoma.
Mimae T; Tsuta K; Maeshima AM; Okada M; Asamura H; Kondo T; Tsuda H
Pathol Res Pract; 2012 Sep; 208(9):534-40. PubMed ID: 22824147
[TBL] [Abstract][Full Text] [Related]
26. [Cathepsin D activity in gastric cancer].
Kantsaliev AL; Kozyreva EA; Kushlinskiĭ NE; Rottenberg VI; Klimenkov AA; Vasil'ev AV
Vopr Onkol; 1994; 40(1-3):40-6. PubMed ID: 7701792
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical visualisation of cathepsin-D expression in breast cancer.
Barthell E; Mylonas I; Shabani N; Kunze S; Kuhn C; Jeschke U; Friese K
Anticancer Res; 2007; 27(4A):2035-9. PubMed ID: 17649818
[TBL] [Abstract][Full Text] [Related]
28. Cathepsin B in the growth of colorectal cancer: increased activity of cathepsin B in human colorectal cancer.
Satoh Y; Higashi T; Nouso K; Shiota T; Kinugasa N; Yoshida K; Uematsu S; Nakatsukasa H; Nishimura Y; Tsuji T
Acta Med Okayama; 1996 Dec; 50(6):305-11. PubMed ID: 8985467
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
30. Tissue microarray-determined expression profiles of cyclooxygenase-2 in colorectal adenocarcinoma: association with clinicopathological parameters.
Wu CY; Lee WH; Wang JY; Chiang H; Chang JL; Tsai WC; Sheu LF; Jin JS
Chin J Physiol; 2006 Dec; 49(6):298-304. PubMed ID: 17357536
[TBL] [Abstract][Full Text] [Related]
31. Cathepsin D immunocytochemical assays in breast carcinomas: image analysis and correlation to prognostic factors.
Charpin C; Devictor B; Bonnier P; Andrac L; Lavaut MN; Allasia C; Piana L
J Pathol; 1993 Aug; 170(4):463-70. PubMed ID: 8410496
[TBL] [Abstract][Full Text] [Related]
32. Relationship between cathepsin B, cathepsin D expression and biological behaviour in mucinous colorectal carcinoma.
Wang Y; Lin X
Chin Med Sci J; 2004 Mar; 19(1):12. PubMed ID: 15104218
[No Abstract] [Full Text] [Related]
33. 5-Lipoxygenase is coexpressed with Cox-2 in sporadic colorectal cancer: a correlation with advanced stage.
Barresi V; Grosso M; Vitarelli E; Tuccari G; Barresi G
Dis Colon Rectum; 2007 Oct; 50(10):1576-84. PubMed ID: 17762961
[TBL] [Abstract][Full Text] [Related]
34. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
[TBL] [Abstract][Full Text] [Related]
35. [Cathepsin D expression in primary breast cancer. Comparison of immunohistochemical and biochemical results].
Göhring UJ; Ingenhorst A; Crombach G; Scharl A
Pathologe; 1993 Dec; 14(6):313-7. PubMed ID: 8121884
[TBL] [Abstract][Full Text] [Related]
36. [The expression of cathepsin-D in salivary adenoid cystic carcinoma].
Peng X; Yu G; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2000 May; 35(3):206-8. PubMed ID: 11780226
[TBL] [Abstract][Full Text] [Related]
37. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of serum cathepsin B and D in relation to clinicopathological staging of colorectal cancer.
Skrzydlewska E; Sulkowska M; Wincewicz A; Koda M; Sulkowski S
World J Gastroenterol; 2005 Jul; 11(27):4225-9. PubMed ID: 16015694
[TBL] [Abstract][Full Text] [Related]
39. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
[TBL] [Abstract][Full Text] [Related]
40. Immuno-histochemical evaluation of Cathepsin D in malignant salivary gland carcinomas.
Sivaranjini Y; Angadi PV; Kumar GS
Gulf J Oncolog; 2012 Jan; (11):38-44. PubMed ID: 22227544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
